by Raynovich Rod | Jun 28, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, coronavirus vaccine, vaccines
Update-5 JY 7 After close with NASDAQ down 0.86%, but biotechs hold. Genmark (GNMK) up 10.33% AH to $17.22 on Preliminary q2 Results. Revs of $40.1M, a 118% increase over Q2 2019, Placed 71 new ePlex analyzers for a total installed base of 650. Added to VIR Bio (VIR)...
by Raynovich Rod | Apr 30, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, vaccines
5/11/20 330p EDT Crazy market running up again in healthcare, life sciences and biotech; cyclicals continue to lag. XBI break-out to new highs at $104 up 4.7%. IBB up 3.94% to $133. This run reminds me of JY 2015 last big blowoff and speculative frenzy. But small...
